<unk>  is a bradykinin B2 receptor antagonist that is FDA approved for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.   Common adverse reactions include pyrexia, transaminase increase, dizziness, and rash.
Icatibant
Suvorexant
Tasimelteon
Atogepant
Toremifene
Vigabatrin
Fosaprepitant
Stiripentol